Jan 27 (Reuters) - UnitedHealth (UNH) on Tuesday forecast 2026 adjusted profit slightly above analysts' estimates, in a sign that medical cost-control measures under CEO Stephen ​Hemsley were beginning to reap results. Hemsley, who returned as CEO in May to restore ‌investor and consumer trust in the healthcare behemoth, has been working to steer the company out of a ‌difficult period that included the murder of a top executive, a surge in medical costs, a federal probe, and Americans' anger at insurance ...

UnitedHealth on Tuesday forecast 2026 adjusted profit slightly above analysts' estimates, in a sign that medical cost-control measures under CEO Stephen Hemsley were beginning to reap results. ...

Core Viewpoint - UnitedHealth Group reported a modest earnings beat for the fourth quarter but provided soft revenue guidance for 2026, indicating challenges due to higher medical costs and a strategic turnaround plan [1][3]. Financial Performance - For the fourth quarter, UnitedHealth's adjusted earnings per share were $2.11, slightly above the expected $2.10, while revenue was $113.2 billion, below the anticipated $113.82 billion [9]. - The company expects 2026 revenue to exceed $439 billion, reflecting a 2% year-over-year decline, which is the first revenue decline in a decade [3][4]. Strategic Changes - UnitedHealth is implementing a turnaround strategy that includes shrinking membership, raising prices, cutting benefits, and increasing transparency to restore profitability and reputation [2]. - The company is focusing on American domestic businesses and divesting operations in the U.K. and South America [5]. Membership and Medical Costs - A significant decline in U.S. membership is expected, with a reduction of more than 3 million members in 2026 [4]. - Medical costs for Medicare Advantage patients have increased due to a rise in hospital visits for delayed procedures, although costs in the fourth quarter were high but not exceeding expectations [7]. Medicare Impact - The transition to Medicare's new coding system (V28) is expected to result in a $6 billion revenue hit in 2026, affecting both UnitedHealthcare and its Optum health-care unit [5]. - Proposed flat payment rates for Medicare Advantage by the Centers for Medicare and Medicaid Services have negatively impacted shares of UnitedHealth and other insurers [6]. Medical Benefit Ratio - For 2026, UnitedHealth anticipates a medical benefit ratio of 88.8%, an improvement from the 89.1% ratio reported for 2025, indicating better profitability [8].

Core Insights - UnitedHealth Group reported consolidated revenues of $447.6 billion for 2025, reflecting a 12% year-over-year growth, and provided an optimistic outlook for 2026 with projected revenues exceeding $439.0 billion [2][10][23] - The company emphasized its commitment to improving operational transparency and performance, which is expected to enhance its service delivery and growth trajectory [4][19] Financial Performance - For 2025, earnings from operations were $19.0 billion with a net margin of 2.7%, while cash flows from operations reached $19.7 billion, equating to 1.5 times net income [2][10] - The adjusted earnings from operations for 2025 were reported at $21.7 billion, excluding a $2.8 billion charge related to cyberattack costs and restructuring efforts [10][30] Segment Performance - UnitedHealthcare served 49.8 million consumers in 2025, generating revenues of $344.9 billion, a 16% increase from the previous year [6][15] - Optum's revenues grew by 7% to $270.6 billion, supporting over 123 million consumers across its various businesses [6][12] 2026 Outlook - The company anticipates earnings from operations to exceed $24.0 billion in 2026, with an adjusted earnings outlook greater than $17.75 per share [21][23] - The projected medical care ratio for 2026 is expected to improve to 88.8%, reflecting ongoing repricing efforts and operational efficiencies [23][27] Operational Changes - UnitedHealth Group has implemented measures to enhance operational transparency, including independent reviews of business practices [4] - The company is focusing on aligning pricing strategies with higher medical trends and health care policy changes to ensure sustainable growth [6][10]

State-owned utility Uniper expects a first tender for new German power plant capacity to take place in the second half of the year, its CEO Michael Lewis said, adding the firm was still prepared to co... ...

Market Overview - U.S. stock futures showed volatility, fluctuating between gains and losses following a higher close on Monday [1] - Major benchmark indices had mixed futures, with the Dow Jones down 0.11%, S&P 500 up 0.23%, and Nasdaq 100 up 0.52% [3][9] Federal Reserve Insights - The Federal Reserve is set to begin its first two-day policy meeting of the year, with a 97.2% likelihood of maintaining current interest rates [2] Company Earnings and Performance - General Motors (NYSE: GM) is projected to report quarterly earnings of $2.20 per share on revenue of $45.80 billion, with a premarket decline of 0.48% [7] - UnitedHealth Group (NYSE: UNH) is expected to report earnings of $2.10 per share on revenue of $113.82 billion, experiencing a premarket drop of 8.24% [7] - Nucor Corp. (NYSE: NUE) reported quarterly earnings of $1.73 per share and revenue of $7.687 billion, both missing analyst expectations, leading to a decline of 3.11% [7] - Humana Inc. (NYSE: HUM) shares fell 12.23% due to a proposal to keep payment rates for private Medicare plans flat [14] - Cloudflare Inc. (NYSE: NET) saw a rise of 7.73% amid social media excitement over an AI project [14] Analyst Insights - Professor Jeremy Siegel maintains an optimistic outlook for 2026, emphasizing a productivity revival driven by technology and a positive trajectory for the economy and markets [10][11] - Siegel notes that small-cap and value stocks are outperforming early in 2026, indicating a shift in market focus [11][12]

Market Sentiment - The CNN Money Fear and Greed index showed an improvement in overall market sentiment, remaining in the "Neutral" zone with a reading of 55.3, up from 53.7 [5][6] - U.S. stocks settled higher on Monday, with the Dow Jones index gaining over 300 points, closing at 49,412.40, while the S&P 500 rose 0.50% to 6,950.23 and the Nasdaq Composite gained 0.43% to 23,601.36 [4] Company Performance - Revolution Medicines Inc (NASDAQ:RVMD) shares dropped 17% following reports that Merck is no longer in discussions to acquire the company [2] - Steel Dynamics Inc (NASDAQ:STLD) reported downbeat earnings for the fourth quarter [2] Economic Data - The Chicago Fed National Activity Index improved to -0.04 in November from -0.42 in October [3] - U.S. durable-goods orders rose 5.3% month-over-month in November, following a revised 2.1% decline in October, exceeding market estimates of a 3.7% increase [3] Sector Performance - Most sectors on the S&P 500 closed positively, with communication services, information technology, and utilities stocks recording the biggest gains, while consumer discretionary and consumer staples stocks closed lower [4]

Core Viewpoint - U.S. stock futures are mixed, with several companies expected to report earnings that may attract investor attention today [1] Group 1: Earnings Reports - General Motors Co (NYSE:GM) is expected to report quarterly earnings of $2.20 per share on revenue of $45.80 billion, with shares falling 0.5% to $79.05 in after-hours trading [1] - W R Berkley Corp (NYSE:WRB) reported quarterly earnings of $1.13 per share, meeting analyst expectations, while sales of $3.721 billion exceeded estimates of $3.661 billion, leading to a 1.2% increase in shares to $67.71 [1] - Boeing Co (NYSE:BA) is anticipated to post a quarterly loss of 39 cents per share on revenue of $22.47 billion, with shares rising 0.1% to $248.52 in after-hours trading [1] - Nucor Corp (NYSE:NUE) reported quarterly earnings of $1.73 per share, missing the consensus estimate of $1.91 per share, and sales of $7.687 billion also fell short of the $7.868 billion estimate, resulting in a 3.1% decline in shares to $172.13 [1] - UnitedHealth Group Inc (NYSE:UNH) is expected to report quarterly earnings of $2.10 per share on revenue of $113.82 billion, with shares dropping 8.7% to $321.22 in after-hours trading [1]

RT Watcher.Guru (@WatcherGuru)Last month, Rep. Kevin Hern sold up to $500,000 worth of UnitedHealth stock.Today, the Trump administration proposed flat Medicare reimbursement rates for insurers, causing $UNH to crash over 10%.Hern is a member of the House Subcommittee on Health. https://t.co/fZBPjriGkR ...

Core Viewpoint - The proposed maintenance of the Medicare Advantage payment rates at current levels for next year has disappointed investors, leading to significant stock declines for major insurance companies [1]. Group 1: Payment Rate Impact - The Centers for Medicare & Medicaid Services (CMS) announced that the payment rate for Medicare Advantage plans is expected to increase by only 0.09% in 2027, far below analysts' expectations of a 6% increase [1][2]. - The total payment increase for Medicare Advantage plans in 2027 is projected to be just $700 million, which is minimal compared to the typical payment growth in the tens of billions [2]. - Payment rates are crucial for large insurers like UnitedHealth, CVS Health, and Humana, as the Medicare Advantage program has been a significant growth driver for the insurance industry over the past decade [1][3]. Group 2: Industry Challenges - The profitability of Medicare Advantage plans has been declining due to rising medical costs and insufficient government funding, leading to pressure on insurers [1][3]. - The insurance industry has expressed concerns that the government's payment levels have not kept pace with rising costs, impacting their profit margins [3]. - Analysts had previously predicted a payment increase of 5% to 6% for 2027, and a lower increase could significantly pressure insurance company stock prices [3].